The ANA (antinuclear antibody) test screens blood for antibodies that target cell nuclei, used as an initial test for suspected systemic autoimmune diseases (e.g., lupus, Sjögren’s, scleroderma). ENA (extractable nuclear antigen) testing identifies specific autoantibodies (Ro/SSA, La/SSB, Sm, RNP, Scl‑70, Jo‑1, etc.) to clarify diagnosis, predict disease type and guide management. Both require a blood sample and clinical correlation.

The ANA to ENA profile is a blood test that first screens for antinuclear antibodies (ANA) and, if positive, identifies specific extractable nuclear antigen (ENA) antibodies (e.g., anti‑Ro, La, Sm, RNP, Scl‑70). It helps diagnose and differentiate systemic autoimmune diseases such as lupus, Sjögren’s, scleroderma and mixed connective tissue disease, guiding prognosis and treatment decisions.

ENA (extractable nuclear antigens) are specific nuclear proteins targeted by certain antinuclear antibodies. ENA isn’t a separate kind of ANA but a panel identifying specific antibodies within the ANA family (e.g., anti-Ro/SSA, anti-La/SSB, anti-Sm, anti-RNP, anti-Scl-70, anti-Jo-1). ENA testing refines diagnosis and guides management when ANA is positive.

If ANA is positive but ENA panel is negative, it means antinuclear antibodies are present but no specific extractable nuclear antigen antibodies were detected. This can reflect nonspecific autoimmune activity, early or drug-related autoimmunity, infection, or even a healthy incidental finding. A negative ENA lowers likelihood of certain connective-tissue diseases but does not rule them out—clinical correlation and repeat or additional testing may be recommended.

ENA stands for Extractable Nuclear Antigen(s). It denotes a group of cellular proteins that can trigger autoantibody production in systemic autoimmune diseases. ENA testing detects antibodies (for example, anti‑Ro, anti‑La, anti‑Sm, anti‑RNP) and helps diagnose and monitor conditions such as systemic lupus erythematosus and Sjögren’s syndrome, complementing other autoimmune serology tests.

Early signs of lupus in females can include persistent fatigue, low‑grade fever, joint pain and swelling, and a butterfly‑shaped rash across the cheeks and nose. Other early features are photosensitivity, patchy hair loss, mouth or nasal ulcers, swollen glands, Raynaud’s phenomenon, chest pain with breathing, and cognitive fog or memory problems.